While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.

Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Albert Bourla, the CEO of pharmaceutical company Pfizer ($PFE), plans to meet with activist investor Starboard Value in ...

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

Pfizer Inc.'s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too. Spreads on the company's ...

PFE obtains $1 billion from activist investor Starboard Value. Stock gains on hopes of a plausible turnaround of the ...

Starboard has prepared a pitch deck about its turnaround plans for Pfizer but this has yet to be circulated to the drugmaker’s directors and investors, said two people familiar with the matter. But ...